Takeda Pharma sp. z o.o. in Poland has appointed Sameha Rafla as CEO.
Sameh Rafla brings to the organization comprehensive international experience in team building and setting patient-focused goals and directions. Prior to joining the Polish team, he led the Takeda Europe and Canada (EUCAN) transplant franchise, where he was responsible for the company's entry into the transplant field.
In his career, Sameh Rafla managed Takeda's product portfolio in the EUCAN Rare Metabolic Diseases and R...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in